Shiseido studies hair generation technologies, targets male baldness and female hair thinning

The studies are based on Canada’s RepliCel hair regeneration technology RCH-01, and after initial safety studies abroad which went without problems clinical studies are now planned in Japan.

Nikkei Biotech news release, March 3, 2015; Shiseido website

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny